Ischemic heart disease Board decisions

The appeal for an increased evaluation in excess of 10 percent for service-connected valvular heart disease with sinus bradycardia has been withdrawn by the Veteran.

The Board granted service connection for coronary artery disease and diabetes mellitus, type II, due to presumed exposure to herbicides at Fort McClellan. The claims for gastroesophageal reflux disease, hypertension, sinusitis, diverticulitis, and fibromyalgia were remanded for further development.

The Board granted service connection for the cause of the Veteran's death, finding that his coronary artery disease, atrial fibrillation, and hypertension were etiologically related to active duty service.

The Board denied service connection for asthma, COPD, CAD (claimed as heart disease), DMII, and a kidney disorder based on the evidence not persuasively supporting an in-service incurrence or relationship to service.

The appeal for an earlier effective date for the grant of service connection for CAD with cardiomyopathy, for the purposes of accrued benefits, is dismissed as moot.

The appeal is remanded to correct duty to assist errors that occurred prior to the July 2021 rating decision.

The Board granted service connection for a cervical spine disability, lumbar spine disability, and coronary artery disease (CAD) based on in-service exposure to high G-forces as a fighter pilot or due to in-service hyperlipidemia.

The Board denied the veteran's claims for a compensable rating for bilateral hearing loss, an earlier effective date for the 100 percent evaluation of coronary artery disease (CAD), and entitlement to TDIU and DEA benefits prior to August 16, 2022.

The Board granted service connection for multiple myeloma, hypertension, and heart disease based on the Veteran's exposure to herbicide agents during his service at Fort Gordon.

The Board remands the service connection claim for a cardiovascular disorder, as new and relevant evidence has been received since the prior denial.

The Board remands the claims for further development and readjudication by the Regional Office due to a duty to assist error regarding the verification of in-service exposure to herbicide agents or other toxic exposure risk activities.

The Board remands the claim for service connection of a heart disability to verify possible herbicide exposure at Camp Lejeune.

The Board denied the veteran's claims for higher ratings for hypertension, arteriosclerotic heart disease, and diabetes mellitus.

The Board remands the service connection claim for arteriosclerotic heart disease and myocardial infarction to obtain an opinion regarding the relationship between the Veteran's condition and toxic exposure risk activities as required by the PACT Act.

The Board granted service connection for coronary artery disease as secondary to the Veteran's service-connected post-traumatic stress disorder.

The Board granted service connection for diabetes mellitus type II, coronary artery disease, Parkinson's disease, and neuropathy, as due to herbicide exposure or secondary to a service-connected condition.

The Veteran's service-connected coronary artery disease with mitral and tricuspid valve regurgitation status-post angioplasty renders him unable to secure or follow a substantially gainful occupation from February 5, 2016 through November 28, 2023.

The veteran's appeal for service connection for coronary artery disease and congestive heart failure was denied due to a late filing of the appeal request.

The Board denied entitlement to an initial rating in excess of 30 percent for IHD s/p CABG from August 31, 2010 to May 2, 2017 and a rating in excess of 60 percent for the same condition from May 3, 2017 to June 28, 2019 and October 1, 2019 to April 21, 2021.

The Board granted service connection for the Veteran's cause of death, finding that his presumed exposure to herbicide agents in Vietnam contributed to ischemic heart disease (IHD) and ultimately led to cardiopulmonary arrest.